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Abstract
Background: Copy number variations (CNVs) having no (obvious) clinical effects were rediscovered as major part of
human genome in 2004. However, for every cytogeneticist microscopically visible harmless CNVs (CG-CNVs) are well
known since decades. Harmless CG-CNVs can be present as heterochromatic or even as euchromatic variants in
clinically healthy persons.
Results: Here I provide a review on what is known today on the still too little studied harmless human CG-CNVs,
point out which can be mixed up with clinically relevant pathological CG-CNVs and shortly discuss that the artificial
separation of euchromatic submicroscopic CNVs (MG-CNVs) and euchromatic CG-CNVs is no longer timely.
Conclusion: Overall, neither so-called harmless heterochromatic nor so-called harmless euchromatic CG-CNVs are
considered enough in evaluation of routine cytogenetic analysis and reporting. This holds especially true when
bearing in mind the so-called two-hit model suggesting that combination of per se harmless CNVs may lead to
clinical aberrations if they are present together in one patient.
Keywords: Heteromorphism, Copy number variations (CNVs), Banding cytogenetics, Molecular cytogenetics,
Euchromatic variants (EVs)
Background
In 2004 it was a kind of big surprise for geneticists that
within the human genome there are hundreds or more
regions prone to so-called submicroscopic copy number
variations (CNVs) [1–3]. As this kind of CNVs is detect-
able primarily by molecular genetics, they are abbrevi-
ated as MG-CNVs in the following. These MG-CNVs
are located in euchromatic regions of, and dispersed
over the entire human genome. They are detected by
microarray-analyses in each healthy as well as in each
(due to other reasons) diseased person [1–4]. Even
though still it is not clear if such repeatedly found MG-
CNVs have any kind of long term effects on e.g. health,
cancer susceptibility, intelligence or life expectance [5–7],
at present they are considered as harmless and as not
worth to be reported [8].
Before detection of MG-CNVs in 2004 [1–3] it was
suggested that no two clinically healthy individuals in
human, apart from monozygote twins, are alike due to
different gene/allele combinations and point mutations
leading to new alleles along the human genome [9]. This
is emphasized e.g. by the possibility to perform paternity
tests based on single nucleotide polymorphisms [10].
However, studying thousands of patients and normal
controls by microarray revealed, that each person distin-
guishes from another in euchromatic MG-CNVs by the
size of up to 1.5 megabasepairs (Mb); also several
0.1 Mb of MG-CNVs are lost or amplified during mei-
osis from generation to generation [11].
Still, considering what was known and common sense
among cytogeneticists on harmless cytogenetically visible
CNVs (= CG-CNVs) since decades, the excitement from
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2004 is somehow unknowable. Harmless CG-CNVs
were first found as heterochromatic variants in the
1960s [12, 13] and later-on in the 1990s even as eu-
chromatic variants (EVs) in clinically healthy persons
(for review see [14, 15]). An already early finding of
cytogenetics was that on chromosomal level the num-
bers and kinds of CG-CNVs detected during routine
cytogenetics is high; this led to the statement that there
are no individuals which are really the same on a
chromosomal level, especially concerning the pericen-
tric regions, the acrocentric short arms and - in male -
cytoband Yq12 [12, 13, 15]. Thus, the gender-specific
interindividual differences in genome size are for sure
not only in an average range of only 0.5 Mb as previ-
ously suggested [11]; based on variety of heterochro-
matic CG-CNVs at least 2-4 Mb have to be added.
In the following a review on the overall too little stud-
ied, so-called harmless human CG-CNVs is provided, in-
cluding what is nowadays known on their standard sizes
and their anchorage within the human reference gen-
ome. As, according to the literature, the major import-
ance of these harmless CG-CNVs is to know the
available tools to distinguish them from clinically rele-
vant pathological CG-CNVs, this is also a point covered
here. Finally, the question of reporting CG-CNVs and
MG-CNVs is discussed in light of the so-called two-hit
model, suggesting that combination of at least two per
se harmless CNVs may lead to clinical aberrations if they
are present together in one individual [11].
What are harmless human CG-CNVs and where are they
localized?
Harmless human CG-CNVs can include heterochro-
matic and even euchromatic regions. Euchromatic re-
gions are here designated as such which contain genes
and are sequence- and alignable. The constitutive het-
erochromatin, was already earlier defined as “regions
that are generally late replicating, rich in repetitive DNA
sequences, and genetically inert” [16], and as “that por-
tion of the genome that remains condensed and in-
tensely stained with DNA intercalating dyes throughout
the cell cycle. It represents a significant fraction of most
eukaryotic genomes and is generally associated with
pericentric regions of chromosomes. Contrary to eu-
chromatin, heterochromatic regions consist predomin-
antly of repetitive DNA, including satellite sequences
and middle repetitive sequences related to transposable
elements and retroviruses. Although not devoid of genes,
these regions are typically gene-poor. Establishment of
heterochromatin depends on two basic elements: the
histonemodification code and the interaction of nonhis-
tone chromosomal proteins” [17].
CG-CNVs can be found mostly at specific spots of the
human genome as shown in Fig. 1. Heterochromatic
CG-CNVs seem to be restricted to pericentric regions of
all human chromosomes, all acrocentric short arms and
the regions 1q12, 9q12, 16q11.2 and Yq12. Euchromatic
CG-CNVs can be divided in such which are repeatedly
found and such which are rarely reported. Repeatedly
Fig. 1 Heterochromatic regions (CG-CNVs) and euchromatic variants (EVs). CG-CNVs and EVs of the human genome are highlighted in a schematically
depicted haploid set of human chromosomes
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found ones are called “euchromatic variants” (EVs) and
are located in 4p16, 8p23.1, 9p12, 9q13-q21.12, 15q11.2
and 16p11.2 (Fig. 1) [14, 15]. Less frequently found eu-
chromatic CG-CNVs, which are not treated here in
more detail, include the majority of all pericentric re-
gions and are most often gains of copy numbers due to
presence of small supernumerary marker chromosomes
(for review see [18]). Finally, CG-CNVs can be present
in single cases / families at various regions of the human
genome as deletions or duplications (for review see
[15]). In the later only occasionally observed cases large
euchromatic deletions or duplications (in the range of 5
or more Mb) do not lead to any clinical problems in the
corresponding carriers; those are called carriers of un-
balanced chromosome abnormalities without phenotypic
consequences (UBCA) [14]. It remains to be determined
if this is, as in case of EVs due to absence of dosage
dependent genes in the affected copy number altered re-
gions of the genome, or due to other reasons, as recently
discussed by Crabtree [19, 20] and Mitchell [21]. The
text below refers only to harmless euchromatic CG-
CNVs which were mentioned before as EVs.
While due to technical reasons heterochromatic CG-
CNVs cannot be detected by microarray-technologies,
euchromatic CG-CNVs can be found there together with
other MG-CNVs. In rare cases MG-CNVs can even have
such a size that they become visible on the banding
cytogenetic level and are detectable also by molecular
cytogenetics [22]. Thus, it has been postulated that MG-
CNVs and euchromatic CG-CNVs are biologically the
same [15]. The latter may also partly explain the event
of rare UBCAs, which, similar to MG-CNVs can be dis-
persed throughout all the genome (for localization of
most frequent MG-CNVs see [23] Fig. 3).
Standard sizes of harmless human CG-CNVs
Yet there are, due to lack of data, no standard sizes de-
fined for MG-CNVs and for euchromatic CG-CNVs. In
other words, it is not known what is to be considered as
‘the normal size’ of those regions [14, 15]. For euchro-
matic CG-CNVs it can be at least stated that as long as
the corresponding regions show a GTG-banding pattern
according to the actual international system for human
cytogenetic nomenclature [24] they seem to have a size
in the normal range. Still, as the resolution of banding
cytogenetics is below 5-10 Mb this still leaves space for a
wide range of variability. Also, euchromatic CG-CNVs
and MG-CNVs, the latter being per definition euchro-
matic, are anchored in the human reference sequence,
i.e. in genome browsers [15], given there as copy number
variant, but no standard size is available from there, as
well.
For heterochromatic CG-CNVs the story is much
more complicated. First of all these regions are not
depicted in the human reference sequence. It is argued
that this is due to the facts that, (i) nothing is known
about the DNA-sequences present there, and (ii) that
these regions cannot be sequenced and aligned properly,
as they are repetitive. However, both arguments are only
partly true. There are studies from 1980, where re-
searchers managed to clone and sequence multiple so-
called satellite DNAs derived from the centromeres, the
heterochromatic regions on chromosomes 1, 9, 16 and Y
and the acrocentric short arms (for review see [15]). Se-
quences of all centromeric probes used nowadays in mo-
lecular cytogenetic diagnostics are known on their base
pair level. Besides, many other satellite-DNA-sequences
have been reported back in these years, however, later
neither studied any more nor included in the genome
browsers [15].
Furthermore, even though the international system for
human cytogenetic nomenclature [24] was established to
achieve a worldwide uniform nomenclature for descrip-
tion of chromosomal alterations, no universal agreement
has been included there yet, how to define the standard
sizes of (i) centromeres, (ii) heterochromatic regions of
chromosomes 1, 9, 16 and Y or (iii) acrocentric short
arms. As recently shown it is even worse, and e.g. the
sizes of acrocentric short arms vary between different
versions of the international system for human cytogen-
etic nomenclature [15].
Thus, the following norms were suggested:
– Considered as normal could be for short arm sizes
of the acrocentric chromosomes if they are about
the same size of the short arm of a chromosome 18
of the same metaphase spread; in other words if it is
between half of a chromosome 18p and up to 2/3 of
the length of a 17p, the short arm has a normal size.
If smaller than half 18p it is a “p-“ variant and if it is
larger than 2/3 of a 17p it is a ‘p+’ variant [15]
(Fig. 2a);
– for the regions 1q12, 9q12, 16q11.2 and Yq12
normal could be if they have about the same size as
the short arm of chromosome 16 of the same
metaphase spread. As long as the size is in between
half of 16p and complete 16p it is a normal sized
region; if smaller than half 16p it is a “qh-“ variant
and if larger than 16p it is “qh+” variant [15]
(Fig. 2b);
– for centromeric regions visualized by molecular
cytogenetics a norm may be that those are about the
size of a chromatid (Fig. 2c).
Frequencies of harmless human CG-CNVs
Incidences of euchromatic CG-CNVs in human popula-
tion are not available from the literature yet. For MG-
CNVs, at least some of them are known to be more
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frequent than others; still, one has to consider that most
available data for MG-CNVs was obtained from
Caucasian people, while highest variance is to be ex-
pected for Africans [25]. Undoubtedly the MG-CNV
present in 15q11.2, also being an EV, is a really common
variant seen in many samples in diagnostics; for sure de-
pending on the used reference, it is expresses as gain or
loss of copy numbers [26].
As especially heterochromatic CG-CNVs seem to have
no direct impact on the phenotype [15], these genomic
regions do not underlie the same evolutionary rules as
other ones. Thus, these regions may be enlarged or
smaller, duplicated, inverted or otherwise rearranged,
and these changes may be stabilized within a population
[27]. Especially, the short arms of the acrocentric chro-
mosomes being in major parts identical and present in
overall 10 copies per cell show nicely this effect. The
aforementioned fact that there are practically no single
individuals (maybe apart from monozygotic twins),
which are really alike on chromosomal level, is mainly
due to the variations of acrocentric short arms.
Even though not based on uniform assessments (see
part for standard sizes of CG-CNVs) there is data avail-
able on approximate frequencies of harmless hetero-
chromatic CG-CNVs as summarized in Table 1. The
most frequently observed chromosomal heteromorphism
is an inversion polymorphism of chromosome 9, for
which my group previously showed that this includes at
least 37 different variants in parts combined with CG-
CNVs of this chromosomal region and resolvable by
molecular cytogenetics [28]. Given the statement on ac-
rocentric short arms before, it is not surprising that
length variations of those are present in ~2.5 % of the
general population. Due to technical reasons the acro-
centric p- and p + variants could not be further distin-
guished as cases with inversions, loss of nucleolus
organizing regions (NOR), translocations or other rear-
rangements, even though they exist (see Figs. 3a-d and
Fig. 2 ‘Normal sizes’ of heterochromatic regions within the human
genome. a) Acrocentric short arms are normal size if they have a
length between half of 18p and 2/3 of 17p; three different variants
all considered as ‘normal’ are depicted for chromosome 14 in the
center part of this figure. An example each, for a 14p- and a 14p +
are shown left right of these three normal chromosome 14 variants.
b) For 9q12 three normal sized variants are shown here as before for
14p in figure-part A. Normal sized is for 9p12 if it is between half size
of 16p and full 16p. 9qh- and 9qh + are shown as well correspondingly
smaller than half of 16p or larger than whole 16p. c) For centromeric
size the reference size may be the diameter of a chromatide of
the same metaphase or stained chromosome. Cen- and cen +
heteromorphisms are clearly smaller or larger than a chromatide
diameter, respectively
Table 1 Frequency of CG-CNVs in general human population










The data was adapted from [15]
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elsewhere [15]); their frequencies were never studied
and/or reported.
CG-CNVs in diagnostics
From the above mentioned data it may be obvious
already, that CG-CNVs may be a more than suited target
of future research. Still CG-CNVs play also a role in
diagnostics and are matter of discussion concerning the
attention which is necessary to be given to them in
terms of detailed evaluation and reporting [15, 29].
Heterochromatic CG-CNVs in metaphase-diagnostics
Examples how heterochromatic CG-CNVs may look like
can be found in Fig. 2a-g; more examples can be found
elsewhere [15]. Some of them can really make you
worried and suggest that there is not only heterochro-
matin involved but maybe something like balanced or
unbalanced translocations behind. Thus molecular cyto-
genetic studies are necessary to resolve the findings;
suited probes may be directed against centromeric re-
gions, 15p11.2 (D15Z1), 22p11.2 (D22Z4), NOR, short
arms of all acrocentrics, and Yq12 [15, 30]. Based on
such studies one may learn more about how these
CG-CNVs may be formed, e.g. by unequal crossing-
over events, translocations or amplifications/deletions.
Still systematic studies therefore lack [15].
The necessity for thorough characterization, de-
scription and reporting of heterochromatic CG-CNVs
in diagnostics is highlighted by the following
examples:
Fig. 3 Eight examples of CG-CNVs. Here examples of CG-CNVs are presented as characterized by molecular cytogenetic based hybridization done
using probes and protocols as previously reported [15]. All eight studied persons were clinically normal and studied cytogenetically either prenatally,
due to infertility or it was a parental analysis due to a clinically affected child. In each part of the figure the studied chromosome pair is indicated at
top, the ‘abnormal’ chromosome is shown below the corresponding ‘normal’ homologue and the probes used are indicated right-side of the depicted
chromosome. Each chromosome is shown twice: left side just in inverted DAPI-banding and right side fluorescence signals of applied probes
on these chromosomes. a) A chromosomal enlargement of a short arm of a chromosome 15 was identified as a der(15)(pter- > p11.2::p12- >
qter), i.e. an intrachromosomal direct duplication was observed. b) The enlarged short arm of a chromosome 21 showed an amplification
of NOR-sequences, which can be described according to [15] as der(21)(p12amp). c) Similar as in Fig. 3a here a chromosome 22 showed an
intrachromosomal direct duplication, however including even parts of cytoband 22q11.21, with a partial karyotype dic(22)(pter- >
q11.21::p11.2- > qter). d) The result in this case with a strong signal of D22Z4 in 22p11.2 in one and an extremely weak signal of the same
probe on the other chromosome 22 was interpreted as a t(22;22)(p11.2;p11.2). e) For chromosome 3 DAPI-banding is known to reveal multiple
chromosomal heteromorphisms [15]. In this case here chromosome 3 depicted below showed even a conspicuous GTG-banding pattern (not
shown). After application of the available pericentromeric probes for chromosome 3 it was obvious that none of the regions covered by those
probes was involved in this alteration; still DAPI banding pattern was different and enlarged. Thus the conclusion was that a duplication of
satellite I or III DNA reported for that region [15] must be amplified and thus the partial karyotype is: dup(3)(q11.2q11.2). f) In this case also
GTG-banding already showed an aberrant pattern in the pericentric region of a chromosome 3 (not shown). However, here the probe D3Z1
showed two signal on the derivative chromosome 3. Together with the inverted DAPI-banding pattern an inv(3)(q11.1q11.2) was suggested.
g) A similar pattern as for the derivative chromosome 3 from Fig. 3f was seen here for a chromosome 5 after applying the alphoid probe
D5Z2 (identical to D1Z1 and D19Z3). Still, as D5Z2 is located in 5p11.1 only and an enlargement of DAPI-positive region in 5q was visible a
der(5)(pter-> q11.1::p11.1- > p11.1:q11.1- > qter) was reported. h) On the chromosome 8 below an altered distal part of the short arm is visible.
The probe RP11-122 N11 is specific for the known EV in this region; as is gives a significantly stronger signal on the derivative than on the normal
chromosome 8 this prenatal case was considered to carry the known EV without clinical consequences. Later-on a healthy child was born
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– Most important is for sure to distinguish between
heterochromatic CG-CNVs and semicryptic
imbalanced or balanced translocation. An example
was previously reported by our group [30] where an
enlarged p-arm of a chromosome 13 was indicative
for a der(13)t(6;13)(p22.2;p12). Similar cases with
semicryptic translocations can also be found
elsewhere [15, 31].
– In case of enlargement and/or strange banding
pattern of an acrocentric short arm (e.g. Fig. 2a-d)
detected in case of a leukemia sample may suggest
clinically relevant acquired translocations or
oncogene-amplification. In case this was already
found earlier and correctly reported as
heteromorphism in a previous peripheral blood
based chromosomal analyses of the same patient for
other reasons, this possibility can be excluded
immediately and save important diagnostic time and
resources.
– The same holds true for centromeric changes like
shown in Figs. 2e-2g, including centromeric
enlargement, loss or inversions; misinterpretation in
tumor samples can be omitted and additional
clarifying studies are not necessary, if the CG-CNV
was correctly reported previously.
Still many guidelines recommend not to report such
alterations [29, 32], a statement which is only rarely
questioned [15].
Heterochromatic CG-CNVs in interphase-diagnostics
Application of centromeric probes in interphase cells is
a major field of molecular cytogenetics [33]. However,
without having metaphases in parallel one can never be
really sure if the obtained results are interpreted cor-
rectly. There are pitfalls reported when applying
centromeric probes for chromosomes X, Y and 18 in
uncultured amniocytes [34] as well as for a correspond-
ing centromeric probe for chromosome 7 in leukemia
[35]. CG-CNVs being relevant here can mimic chromo-
some loss or gain. Apparent loss can be due to coinci-
dental reduction of alpha-satellite sequences at one
tested centromere; apparent gain can be due to by
chance amplification of the tested sequences at another,
non-homologous chromosome [15, 34, 36]. Thus, in
case of interphase-diagnostics without the possibility to
study metaphases of the patient, locus-specific probes
should always be preferred against heterochromatin-
oriented probes.
Euchromatic CG-CNVs in metaphase-diagnostics
For euchromatic CG-CNVs/EVs two aspects are diag-
nostically relevant. On the one hand there are such EVs
which may be mixed up with adverse copy number
changes of the same regions as reported e.g. for the EVs
in chromosomes 8 (see Fig. 2h) and 16 [14, 15]. Second,
EVs may be a problem in leukemia cases, as EVs may be
misinterpreted as translocations, insertions, deletions or
oncogene-amplifications.
CG-CNVs and MG-CNVs in light of the so-called two-hit
model
As recently stated, “MG-CNVs are determined as vari-
able copy numbers when compared to a reference gen-
ome and may include deletions and duplications of
genomic loci. They may encompass as much as 12 % of
the human genome. Most of them are considered as be-
nign MG-CNVs and are usually inherited from a parent.
When determined as de novo, genomic imbalances are
considered more likely pathological. It is also known that
each human being carries about thousand MG-CNVs
ranging from only a few hundred basepairs to over
1 Mb. The major determinant for the clinical impact of
a CNV seems to be, if dosage sensitive genes are present
in the corresponding DNA-stretch” [23]. Besides, it was
recently found that more than one MG-CNV (larger
than 500 kb) can contribute to phenotypic variability as-
sociated with genomic disorders and may be the reason
for developmental impairment; this phenomenon is
called “two-hit”-model [11]. To the best of my know-
ledge there is no study aligning, or even considering the
possibility that euchromatic, and/or (even though being
less likely) heterochromatic CG-CNV may contribute to
phenotypes or age-related conditions. This is, from my
point of view, something to be tested urgently in fu-
ture! As it is known nowadays that regions of hetero-
chromatic DNA are expressed in early embryogenesis
[15, 17] copy number alterations of these regions
should have some effect.
Conclusion
Besides a unique DNA-primary sequence, each human
has also an individual combination of CG-CNVs and
MG-CNVs; this includes even monozygote twins as dif-
ferences in MG-CNVs were already found there [37, 38].
If a genetic analyses is performed in a person one has to
consider that depending on the chosen test one will al-
ways be blind for a part of his genome. If (molecular)
cytogenetics is done a genome wide view with low
resolution is obtained - including the detection of
heterochromatic CG-CNVs. In case of microarray or
sequencing based studies a high-resolution of the ana-
lyzed genome is the result, but heterochromatic CG-
CNVs are missed as well as the information if a copy
number change is due to an insertion, translocation
or an extra derivative chromosome. Overall, a study
in which MG-CNVs and CG-CNVs are evaluated to-
gether is still waiting to be done. Combining
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(molecular) cytogenetics with molecular genetics
could help to avoid being blind for possible solutions
of yet not understood phenomena in human health.
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